Advertisements

US Judge Backs FDA’s Removal of Lilly’s Weight Loss Drug from Shortage List

by Daisy

A U.S. federal judge has upheld a decision by the U.S. Food and Drug Administration (FDA) to remove Eli Lilly’s weight loss and diabetes drugs, Zepbound and Mounjaro, from the list of medicines in short supply.

This ruling, made on May 7, may disappoint patients hoping for more affordable versions of these popular drugs.

Advertisements

The FDA’s move also affects compounding pharmacies, which had been authorized to produce large quantities of generic versions of these obesity treatments while they were classified as in shortage.

Advertisements

Related Topics:

Advertisements

How to Use L-Carnitine Injections? Detailed Instructions

Who Can Get Weight Loss Injections on Nhs? A Detailed Guide

What Are Lipo C Injection and It’s Benefits

You may also like

blank

Your go-to fitness resource, offering customized workout plans, nutrition guidance, and expert wellness advice. Committed to empowering all fitness levels with cutting-edge tools, reliable content, and a holistic approach to achieving health and vitality.

【Contact us: [email protected]

Copyright © 2023 Gtehy.com